Racial differences in parathyroid hormone dynamics.

Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI). J Bone Miner Res (2011) 1.55

Serum calcium and incident type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Am J Clin Nutr (2016) 1.43

Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab (2012) 1.21

Defining physiologically "normal" vitamin D in African Americans. Osteoporos Int (2011) 1.16

Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrol Dial Transplant (2010) 1.11

Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int (2009) 1.08

Macro- and micronutrients in African-Americans with heart failure. Heart Fail Rev (2006) 0.95

Ethnic differences in parathyroid hormone secretion and mineral metabolism in response to oral phosphate administration. Bone (2009) 0.95

Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int (2011) 0.92

Ethnicity, socioeconomic status, and attainment of clinical practice guideline standards in dialysis patients in the United kingdom. Clin J Am Soc Nephrol (2009) 0.85

Effect of supplemental vitamin D and calcium on serum sclerostin levels. Eur J Endocrinol (2014) 0.84

Associations between serum leptin level and bone turnover in kidney transplant recipients. Clin J Am Soc Nephrol (2010) 0.83

Serum sclerostin levels vary with season. J Clin Endocrinol Metab (2013) 0.83

The relation of serum parathyroid hormone and serum calcium to serum levels of prostate-specific antigen: a population-based study. Cancer Epidemiol Biomarkers Prev (2009) 0.82

Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans. Vasc Health Risk Manag (2007) 0.82

Serum parathyroid hormone levels predict falls in older adults with diabetes mellitus. J Am Geriatr Soc (2008) 0.77

Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis. Osteoporos Int (2016) 0.77

Fibroblast growth factor 23, vitamin D, and health disparities among African Americans with chronic kidney disease. Semin Nephrol (2013) 0.76

Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria. Afr Health Sci (2015) 0.75

Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study. J Hypertens (2016) 0.75

IMPACT OF WEIGHT LOSS AND AEROBIC EXERCISE ON NUTRITION AND BONE MINERAL DENSITY IN AFRICAN AMERICAN AND CAUCASIAN POSTMENOPAUSAL WOMEN. J Aging Res Clin Pract (2013) 0.75

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13

Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87

Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56

A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med (1996) 3.20

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet (1995) 3.18

Vitamin D deficiency in homebound elderly persons. JAMA (1995) 3.09

Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69

Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med (1999) 2.51

High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci U S A (1983) 2.40

Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab (1996) 2.33

Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet (1994) 2.23

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J (2007) 2.17

Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature (1999) 2.17

Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem (1999) 2.16

Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res (1997) 2.11

Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract (1990) 2.02

L-amino acid sensing by the extracellular Ca2+-sensing receptor. Proc Natl Acad Sci U S A (2000) 2.02

Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem (1998) 1.98

Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res (1988) 1.93

Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem (1995) 1.86

DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension (2001) 1.83

Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab (1985) 1.81

The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res (1988) 1.73

The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother (2007) 1.72

Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab (2000) 1.71

Intercellular communication mediated by the extracellular calcium-sensing receptor. Nat Cell Biol (2000) 1.68

Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol (1998) 1.62

Osteocalcin: isolation, characterization, and detection. Methods Enzymol (1984) 1.62

Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A (1995) 1.61

Clostridium difficile in acute and long-stay elderly patients. Age Ageing (1988) 1.60

Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. J Biol Chem (1996) 1.59

Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59

Nomenclature of the proteins of cows' milk--sixth revision. J Dairy Sci (2004) 1.55

Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling. J Clin Endocrinol Metab (1998) 1.55

Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev (1996) 1.51

Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem Biophys Res Commun (2001) 1.48

Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab (1983) 1.45

Assessment of frequency-dependent alterations in the level of extracellular Ca2+ in the synaptic cleft. Biophys J (1997) 1.38

Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med (1980) 1.37

Role of anions in parathyroid hormone release from dispersed bovine parathyroid cells. Proc Natl Acad Sci U S A (1978) 1.36

High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer (2001) 1.36

The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet (1992) 1.35

Human calcium transport protein CaT1. Biochem Biophys Res Commun (2000) 1.33

Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab (1978) 1.33

Identification and localization of extracellular Ca(2+)-sensing receptor in rat intestine. Am J Physiol (1998) 1.33

Reoperative parathyroid surgery for persistent hyperparathyroidism. Surgery (1978) 1.32

Divalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med (1978) 1.32

CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. J Pharmacol Exp Ther (1999) 1.31

Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab (2001) 1.31

Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int (2000) 1.28

Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27

Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest (1996) 1.27

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation (1993) 1.26

The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study. J Clin Endocrinol Metab (1997) 1.26

Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit Care Med (2000) 1.25

Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res (1998) 1.24

Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol (1996) 1.23

Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr (2001) 1.22

Preparation of viable isolated bovine parathyroid cells. Endocrinology (1976) 1.22

Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem (2001) 1.22

Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol (2001) 1.21

Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol (1989) 1.21

Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest (2001) 1.20

Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology (1995) 1.20

A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia (2013) 1.19

Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol (1988) 1.18

Beta-Adrenergic receptor interactions. Direct comparison of receptor interaction and biological activity. J Biol Chem (1976) 1.17

Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology (2000) 1.17

Recruitment and baseline characteristics of participants in the Dietary Approaches to Stop Hypertension trial. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.17

Family studies in patients with primary parathyroid hyperplasia. Am J Med (1977) 1.17

The calcium sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J (2006) 1.17

L-amino acid sensing by the calcium-sensing receptor: a general mechanism for coupling protein and calcium metabolism? Eur J Clin Nutr (2002) 1.16

The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev (1996) 1.16

Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol (1997) 1.16

CaT1 expression correlates with tumor grade in prostate cancer. Biochem Biophys Res Commun (2001) 1.16

Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab (1992) 1.15

Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens (2005) 1.14

The effect of Pb(2+) on the structure and hydroxyapatite binding properties of osteocalcin. Biochim Biophys Acta (2001) 1.14

Calcium-sensing receptor in the rat hippocampus: a developmental study. Brain Res Dev Brain Res (1997) 1.14

Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension (1999) 1.14

Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats. Am J Physiol (1998) 1.13

Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab (2001) 1.13

Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun (1998) 1.13

Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest (1994) 1.13

Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab (1982) 1.13

Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab (2003) 1.12

Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens (2006) 1.12

Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem Biophys Res Commun (1997) 1.12

Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest (2000) 1.11

Recruitment and retention of minority participants in the DASH controlled feeding trial. DASH Collaborative Research Group. Dietary Approaches to Stop Hypertension. Ethn Dis (1998) 1.11

Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol (1996) 1.11

Calcium absorption, bone mass accumulation, and kinetics increase during early pubertal development in girls. J Clin Endocrinol Metab (2000) 1.10

Identification and persistence of beta adrenergic receptors during maturation of the rat reticulocyte. Mol Pharmacol (1977) 1.10

Polyvalent cation receptor proteins (CaRs) are salinity sensors in fish. Proc Natl Acad Sci U S A (2002) 1.10

Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men. J Appl Physiol (1985) (1993) 1.10

A prospective study of calciotropic hormones in pregnancy and post partum: reciprocal changes in serum intact parathyroid hormone and 1,25-dihydroxyvitamin D. Am J Obstet Gynecol (1997) 1.09

A rat kidney-specific calcium transporter in the distal nephron. J Biol Chem (2000) 1.08

The influence of ibuprofen on fracture repair: biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res (1991) 1.08

Use of antibiotics in penetrating craniocerebral injuries. "Infection in Neurosurgery" Working Party of British Society for Antimicrobial Chemotherapy. Lancet (2000) 1.08